Collplant

Israel
Reẖovot, Central District, Israel, 7670104

Company profile

Collplant company profile

CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Rehovot, Israel.

Business identity

Contact email
[email protected]
Phone number
+972 73 2325600
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0+
Founded
1981-01-01, Year

Headquarters

Postal code
7670104
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
12
Total equity funding
$74.8M
Last funding
Post IPO Equity / $2M / 2026-02-05
Last equity funding
Post IPO Equity / $2M
Investors
6
Lead investors
1
Founders
1
Articles
94
Exited on
2002-01-17

Founders and investors

Founders

Oded Shoseyov

Lead investors

Pontifax

Investors

Docor International ManagementMeitav Investment HouseMeitav UnderwritingModgal IndustriesPontifax